CHO microRNA engineering is growing up: Recent successes and future challenges
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
microRNAs with their ability to regulate complex pathways that control cellular behavior and phenotype have been proposed as potential targets for cell engineering in the context of optimization of biopharmaceutical production cell lines, specifically of Chinese Hamster Ovary cells. However, until recently, research was limited by a lack of genomic sequence information on this industrially important cell line. With the publication of the genomic sequence and other relevant data sets for CHO cells since 2011, the doors have been opened for an improved understanding of CHO cell physiology and for the development of the necessary tools for novel engineering strategies. In the present review we discuss both knowledge on the regulatory mechanisms of microRNAs obtained from other biological models and proof of concepts already performed on CHO cells, thus providing an outlook of potential applications of microRNA engineering in production cell lines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
miRBase: integrating microRNA annotation and deep-sequencing data
Kozomara, A., & Griffiths-Jones, S. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq1027 · Cited by 3,634
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
The role of site accessibility in microRNA target recognition
Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U., & Segal, E. (2007) · Nature Genetics · doi:10.1038/ng2135 · Cited by 2,460 · cited 2×
“Algorithms may (1) incorporate other relevant computational predictions, like target site accessibility (Kertesz et al., 2007), (2) take advantage of multi-track measurements, such as matched microRNA and mRNA expression profiles (Bonnet et al.”
A pancreatic islet-specific microRNA regulates insulin secretion
Poy, M. N., Eliasson, L., Krutzfeldt, J., Kuwajima, S., Ma, X., MacDonald, P. E., Pfeffer, S., Tuschl, T., Rajewsky, N., Rorsman, P., et al. (2004) · Nature · doi:10.1038/nature03076 · Cited by 2,102 · cited 1×
“In particular, miR-375 can influence glucose-induced insulin secretion by modulating the expression of myotrophin, a protein potentially involved in cytoskeleton dynamics (Poy et al., 2004).”
BackgroundmiR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
Esau, C., Davis, S., Murray, S. F., Yu, X. X., Pandey, S. K., Pear, M., Watts, L., Booten, S. L., Graham, M., McKay, R., et al. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.005 · Cited by 2,082 · cited 1×
“Application of an LNA antagomir of miR-122 leads to 25–30% reduction of plasma cholesterol levels (Elmen et al., 2008; Esau et al., 2006).”
BackgroundProduction of recombinant protein therapeutics in cultivated mammalian cells
Wurm, F. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1026 · Cited by 2,032
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
LNA-mediated microRNA silencing in non-human primates
Elmén, J., Lindow, M., Schütz, S., Lawrence, M., Petri, A., Obad, S., Lindholm, M., Hedtjärn, M., Hansen, H. F., Berger, U., et al. (2008) · Nature · doi:10.1038/nature06783 · Cited by 1,589 · cited 1×
“Application of an LNA antagomir of miR-122 leads to 25–30% reduction of plasma cholesterol levels (Elmen et al., 2008; Esau et al., 2006).”
BackgroundMiR-33 Contributes to the Regulation of Cholesterol Homeostasis
Rayner, K. J., Suárez, Y., Dávalos, A., Parathath, S., Fitzgerald, M. L., Tamehiro, N., Fisher, E. A., Moore, K. J., & Fernández-Hernando, C. (2010) · Science · doi:10.1126/science.1189862 · Cited by 1,260
The miR-34 family in cancer and apoptosis
Hermeking, H. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.56 · Cited by 1,236 · cited 1×
“miR-34 family members function as potent mediators of the p53-induced apoptotic pathway by targeting anti-apoptotic genes including Bcl-2, and also participate in a positive feedback loop of p53 activation via increased acetylation by targeting SIRT1 deacetylase (Hermeking, 2010).”
BackgroundMicroRNAs in metabolism and metabolic disorders
Rottiers, V., & Näär, A. M. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3313 · Cited by 1,156
A MicroRNA Signature of Hypoxia
Kulshreshtha, R., Ferracin, M., Wojcik, S. E., Garzon, R., Alder, H., Agosto-Perez, F. J., Davuluri, R., Liu, C.-G., Croce, C. M., Negrini, M., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01395-06 · Cited by 1,055 · cited 1×
“These microRNAs are likely to decrease the pro-apoptotic signaling in a hypoxic environment (Kulshreshtha et al., 2007).”
BackgroundMeng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
Gene regulation by transcription factors and microRNAs
Hobert, O. (2008) · Science · doi:10.1126/science.1151651 · Cited by 913 · cited 1×
“They are able to regulate complex networks, due to the fact that a single microRNA can find targets in multiple mRNAs, while each mRNA may in turn contain binding sites for multiple microRNAs (Hobert, 2008).”
BackgroundFasanaro, P., D'Alessandra, Y., Di Stefano, V., Melchionna, R., Romani, S., Pompilio, G., Capogrossi, M. C., & Martelli, F. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800731200 · Cited by 912
Kim, J. Y., Kim, Y.-G., & Lee, G. M. (2012) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-011-3758-5 · Cited by 801 · cited 1×
“This has resulted, at least for antibody products, in yields commonly ranging between 2 and 6 g/l (Wurm, 2004), with titers of 20 g/l being reported (Kim et al., 2012).”
BackgroundThe genomic sequence of the Chinese hamster ovary (CHO)-K1 cell line
Xu, X., Nagarajan, H., Lewis, N. E., Pan, S., Cai, Z., Liu, X., Chen, W., Xie, M., Wang, W., Hammond, S., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1932 · Cited by 785
Self-citationMicroRNA-21 promotes cell transformation by targeting the programmed cell death 4 gene
Lu, Z., Liu, M., Stribinskis, V, Klinge, C. M., Ramos, K. S., Colburn, N. H., & Li, Y. (2008) · Oncogene · doi:10.1038/onc.2008.72 · Cited by 711
miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling
Dávalos, A., Goedeke, L., Smibert, P., Ramírez, C. M., Warrier, N. P., Andreo, U., Cirera-Salinas, D., Rayner, K., Suresh, U., Pastor-Pareja, J. C., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102281108 · Cited by 670 · cited 1×
“They thus coordinate the regulation of fatty acid, triglyceride and cholesterol biosynthesis and uptake (Davalos et al., 2011; Rayner et al., 2010).”
BackgroundModulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
Hatley, M. E., Patrick, D. M., Garcia, M. R., Richardson, J. A., Bassel-Duby, R., van Rooij, E., & Olson, E. N. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.08.013 · Cited by 626 · cited 1×
“(Frezzetti et al., 2011; Guan et al., 2012; Hatley et al., 2010).”
Yamane‐Ohnuki, N., Kinoshita, S., Inoue‐Urakubo, M., Kusunoki, M., Iida, S., Nakano, R., Wakitani, M., Niwa, R., Sakurada, M., Uchida, K., et al. (2004) · Biotechnology and Bioengineering · doi:10.1002/bit.20151 · Cited by 572
The miR-17-5p microRNA is a key regulator of the G1/S phase cell cycle transition
Cloonan, N., Brown, M. K., Steptoe, A. L., Wani, S., Chan, W. L., Forrest, A. R., Kolle, G., Gabrielli, B., & Grimmond, S. M. (2008) · Genome Biology · doi:10.1186/gb-2008-9-8-r127 · Cited by 304 · cited 1×
“For example, the miR-17-5p and miR-20a target E2F1 are transcription factors that promote cell proliferation in normal human cells but induce apoptosis in cancer cell lines (Cloonan et al., 2008; Hackl et al., 2010; Li et al., 2011c; Olive et al., 2010).”
BackgroundLovis, P., Gattesco, S., & Regazzi, R. (2008) · bchm · doi:10.1515/bc.2008.026 · Cited by 257 · cited 1×
“In addition, a number of microRNAs are involved in various aspects of exocytosis that have implications in other human diseases (Lovis et al., 2008; Sullivan et al., 2012; Zhang et al., 2011).”
BackgroundIsotype and glycoform selection for antibody therapeutics
Jefferis, R. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.03.021 · Cited by 252
North, S. J., Huang, H.-H., Sundaram, S., Jang-Lee, J., Etienne, A. T., Trollope, A., Chalabi, S., Dell, A., Stanley, P., & Haslam, S. M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.068353 · Cited by 207 · cited 1×
“Engineering of cell lines has resulted in improved product quality (Huang et al., 2012a; North et al., 2010; Pouilly et al., 2012; Raju et al., 2001) and some improvements in productivity (Figueroa et al.”
BackgroundFunctioning of a metabolic flux sensor in Escherichia coli
Kochanowski, K., Volkmer, B., Gerosa, L., Haverkorn van Rijsewijk, B. R., Schmidt, A., & Heinemann, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1202582110 · Cited by 196
Proteomic analysis of Chinese hamster ovary cells
Baycin-Hizal, D., Tabb, D. L., Chaerkady, R., Chen, L., Lewis, N. E., Nagarajan, H., Sarkaria, V., Kumar, A., Wolozny, D., Colao, J., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300476w · Cited by 178 · cited 1×
“1 (Gammell, 2007; Birzele et al., 2010; Hammond et al., 2011; Johnson et al., 2011; Hackl et al., 2011; Xu et al., 2011; Becker et al., 2011; Hackl et al., 2012b; Hammond et al., 2012b; Baycin-Hizal et al., 2012; Gerstl et al., 2013; Lewis et al., in press; Brinkrolf et al., 2013) and the respective datasets including…”
BackgroundSelf-citationTigges, M., & Fussenegger, M. (2006) · Metabolic Engineering · doi:10.1016/j.ymben.2006.01.006 · Cited by 178 · cited 1×
“This gene has been successfully engineered in CHO cells to improve productivity in the past (Tigges and Fussenegger, 2006).”
BackgroundChinese hamster genome sequenced from sorted chromosomes
Brinkrolf, K., Rupp, O., Laux, H., Kollin, F., Ernst, W., Linke, B., Kofler, R., Romand, S., Hesse, F., Budach, W. E., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2645 · Cited by 166
Self-citationImai-Nishiya (2007) · doi:10.1186/1472-6750-7-84 · Cited by 157 · cited 1×
“, 2011) and a high number of clones have been generated with distinct glycosylation patterns (Borisov et al., 2009; Imai-Nishiya et al., 2007; Yamane-Ohnuki et al., 2004) that enhance the therapeutic efficacy of the product (Jefferis, 2012).”
BackgroundOsterlehner, A., Simmeth, S., & Göpfert, U. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23216 · Cited by 131 · cited 1×
“Methylation of the viral promoters commonly used in mammalian expression vectors is believed to play a role (especially in slow loss of productivity over time) (Osterlehner et al., 2011; Yang et al., 2010).”
BackgroundThe NF-κB member p65 controls glutamine metabolism through miR-23a
Rathore, M. G., Saumet, A., Rossi, J.-F., de Bettignies, C., Tempé, D., Lecellier, C.-H., & Villalba, M. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.05.011 · Cited by 129
Engineering CHO cell growth and recombinant protein productivity by overexpression of miR-7
Barron, N., Kumar, N., Sanchez, N., Doolan, P., Clarke, C., Meleady, P., O'Sullivan, F., & Clynes, M. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.12.005 · Cited by 110 · cited 2×
“In a similar approach, Barron et al. (2011a) identified miR-7 as significantly down-regulated during a temperature shift from 37 °C to 31 °C.”
BackgroundSelf-citationUnraveling the Chinese hamster ovary cell line transcriptome by next-generation sequencing
Becker, J., Hackl, M., Rupp, O., Jakobi, T., Schneider, J., Szczepanowski, R., Bekel, T., Borth, N., Goesmann, A., Grillari, J., et al. (2011) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2011.09.014 · Cited by 98
Self-citationChong, W. P. K., Reddy, S. G., Yusufi, F. N. K., Lee, D.-Y., Wong, N. S. C., Heng, C. K., Yap, M. G. S., & Ho, Y. S. (2010) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2010.03.018 · Cited by 97
A novel microRNA mmu-miR-466h affects apoptosis regulation in mammalian cells
Druz, A., Chu, C., Majors, B., Santuary, R., Betenbaugh, M., & Shiloach, J. (2011) · Biotechnology and Bioengineering · doi:10.1002/bit.23092 · Cited by 92 · cited 4×
“Antisense knockdown of miR-466h-5p delayed apoptosis onset in nutrient-depleted conditions by decreasing Caspase-3/7 activation and increasing cell viability (Druz et al., 2011).”
BackgroundInfluentialSelf-citationDoolan, P., Meleady, P., Barron, N., Henry, M., Gallagher, R., Gammell, P., Melville, M., Sinacore, M., McCarthy, K., Leonard, M., et al. (2010) · Biotechnology and Bioengineering · doi:10.1002/bit.22670 · Cited by 84
Self-citationDruz, A., Son, Y., Betenbaugh, M., & Shiloach, J. (2013) · Metabolic Engineering · doi:10.1016/j.ymben.2012.12.004 · Cited by 73 · cited 3×
“Another member of miR-15a/16 cluster, miR-15a-3p, was shown to induce apoptosis by targeting Bcl-xL, thus activatingCaspase-3/7 and reducing viability in several cancers (Druz et al., 2013).”
BackgroundMethodInfluentialSelf-citationSung, Y. H., Lee, J. S., Park, S. H., Koo, J., & Lee, G. M. (2007) · Metabolic Engineering · doi:10.1016/j.ymben.2007.08.001 · Cited by 70
Allen, M. L., & Antoniou, M. (2007) · Epigenetics · doi:10.4161/epi.2.4.5231 · Cited by 62
Luis Galbete, J., Buceta, M., & Mermod, N. (2008) · Molecular BioSystems · doi:10.1039/b813657b · Cited by 35
Using matrix attachment regions to improve recombinant protein production
Harraghy, N., Buceta, M., Regamey, A., Girod, P.-A., & Mermod, N. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-352-3_7 · Cited by 30 · cited 1×
“These include insulators such as the chicken β-globin HS4 element; (S) MARs — ((Scaffold) Matrix Attachment Factors); STARs (stabilizing anti-repression elements); and UCOEs (ubiquitous chromosome opening elements) (Allen and Antoniou, 2007; Galbete et al., 2009; Harraghy et al., 2012).”
Background
Cited by
The art of CHO cell engineering: A comprehensive retrospect and future perspectives
Fischer, S., Handrick, R., & Otte, K. (2015) · Biotechnology Advances · doi:10.1016/j.biotechadv.2015.10.015 · Cited by 312
Therapeutic glycoprotein production in mammalian cells
Lalonde, M.-E., & Durocher, Y. (2017) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2017.04.028 · Cited by 296
“With growing evidence for their role in diverse biological processes, some microRNA genes serve as novel targets for cell engineering strategies (Muller et al., 2008; Jadhav et al., 2013).”
BackgroundRecent advances in mammalian protein production
Bandaranayake, A. D., & Almo, S. C. (2014) · FEBS Letters · doi:10.1016/j.febslet.2013.11.035 · Cited by 222
“cells has increased to more than US$100 billion and continues to grow [11].”
BackgroundOne-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment
Grav, L. M., Lee, J. S., Gerling, S., Kallehauge, T. B., Hansen, A. H., Kol, S., Lee, G. M., Pedersen, L. E., & Kildegaard, H. F. (2015) · Biotechnology Journal · doi:10.1002/biot.201500027 · Cited by 131
Du, Z., Treiber, D., McCarter, J. D., Fomina‐Yadlin, D., Saleem, R. A., McCoy, R. E., Zhang, Y., Tharmalingam, T., Leith, M., Follstad, B. D., et al. (2015) · Biotechnology and Bioengineering · doi:10.1002/bit.25332 · Cited by 113
Metadata
- Authors
- Jadhav, V., Hackl, M., Druz, A., Shridhar, S., Chung, C.-Y., Heffner, K. M., Kreil, D. P., Betenbaugh, M., Shiloach, J., Barron, N., Grillari, J., & Borth, N.
- Venue
- Biotechnology Advances
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 31
- Issue
- 8
- Pages
- 1501-1513
- ISSN
- 0734-9750 (ISSN-L)
- OpenAlex
- W2124567772
- Cited by
- 85
- References
- 42
- FWCI
- 3.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.